Rob75, RE: NXXI
Date 2007-10-02
"Nutrition 21 reported fiscal Q4 (June 30) revenues of $12 million, a 380% jump over the year-ago number. For the fiscal year, NXXI reported total revenues of $42.1 million compared to $10.7 million last year. Net loss for fiscal year 2007 was $19.1 million, compared to a net loss of $10.3 million in 2006.
Nutrition 21 has grown revenues in each of the last four quarters, excluding a one-time charge in the fourth quarter. And with the investments made during this past year and the recent $17.75 million financing, NXXI is in the strongest position it's ever been to build its brands and to generate sustainable growth in 2008 and beyond.
Bottom Line: Nutrition 21 begins fiscal 2008 with a clean slate, having transitioned from an R&D-focused company to a marketing-driven one selling branded consumer products targeted at diabetes, cardiovascular health, obesity, joint health and other age-related ailments.
At less than $1, NXXI is a very attractive buy. We're looking for the company to transform to profitability in the second half of 2008."
NXXI is currently sitting at its 52 week low.
regards,
gktignol
